Determining whether lower levels of dietary soy can inhibit mammary tumorigenesis and whether Areg expression has potential as a biomarker for predicting breast cancer risk may have important implications for prevention and treatment of this disease. The gene discussed is AREG; the disease is breast carcinoma.